105 results
8-K
EX-99.1
ARWR
Arrowhead Pharmaceuticals Inc.
6 Feb 24
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
4:07pm
plozasiran featuring experts in the treatment and management of lipid and lipoprotein disorders
Completed chronic GLP toxicology for pulmonary candidates
8-K
EX-99.1
ARWR
Arrowhead Pharmaceuticals Inc.
29 Nov 23
Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
4:10pm
why the decrease in atherogenic lipoproteins observed with plozasiran has the potential to prevent cardiovascular outcomes
Completed chronic GLP
424B5
gsvwg
5 Aug 20
Prospectus supplement for primary offering
5:14pm